» Articles » PMID: 36280469

Association of Epicardial Adipose Tissue with Coronary CT Angiography Plaque Parameters on Cardiovascular Outcome in Patients with and Without Diabetes Mellitus

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2022 Oct 24
PMID 36280469
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: We aimed to evaluate the association of epicardial adipose tissue (EAT) with coronary CT angiography (CCTA) plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus.

Methods: Data of 353 patients (62.9 ± 10.4 years, 62% male), who underwent CCTA as part of their clinical workup for the evaluation of suspected or known CAD, were retrospectively analyzed. EAT volume and plaque parameters from CCTA were compared in patients with diabetes (n = 63) and without diabetes (n = 290). Follow-up was performed to record adverse cardiovascular events. The predictive value to detect adverse cardiovascular events was assessed using concordance indices (CIs) and multivariable Cox proportional hazards analysis.

Results: In total, 33 events occurred after a median follow-up of 5.1 years. In patients with diabetes, EAT volume and plaque parameters were significantly higher than in patients without diabetes (all p < 0.05). A multivariable model demonstrated an incrementally improved C-index of 0.84 (95%CI 0.80-0.88) over the Framingham risk score and single measures alone. In multivariable Cox regression analysis EAT volume (Hazard ratio[HR] 1.21, p = 0.022), obstructive CAD (HR 1.18, p = 0.042), and ≥2 high-risk plaque features (HR 2.13, p = 0.031) were associated with events in patients with diabetes and obstructive CAD (HR 1.88, p = 0.017), and Agatston calcium score (HR 1.009, p = 0.039) in patients without diabetes.

Conclusions: EAT, as a biomarker of inflammation, and plaque parameters, as an extent of atherosclerotic CAD, are higher in patients with diabetes and are associated with increased adverse cardiovascular outcomes. These parameters may help identify patients at high risk with need for more aggressive therapeutic and preventive care.

Citing Articles

Composite cardiac computed tomography angiography score for improved risk assessment in chronic coronary syndromes.

Lee S, Giesen A, Mouselimis D, Weichsel L, Giannopoulos A, Nunninger M Sci Rep. 2025; 15(1):3089.

PMID: 39856114 PMC: 11760858. DOI: 10.1038/s41598-025-87118-0.


Getting closer to the coronary arteries: A bibliometric analysis of CT-based adipose tissue imaging in coronary artery disease.

Fu J, Baichoo R, Xiong X, Shen W, Jin K, Guan X Medicine (Baltimore). 2025; 103(47):e40592.

PMID: 39809162 PMC: 11596442. DOI: 10.1097/MD.0000000000040592.


Computed Tomography-Derived Fractional Flow Reserve: Developing A Gold Standard for Coronary Artery Disease Diagnostics.

Hu L, Wang Y, Rao J, Tan L, He M, Zeng X Rev Cardiovasc Med. 2024; 25(10):372.

PMID: 39484113 PMC: 11522765. DOI: 10.31083/j.rcm2510372.


Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study.

Weichsel L, Florian Andre , Renker M, Breitbart P, Overhoff D, Beer M Clin Res Cardiol. 2024; .

PMID: 39080016 DOI: 10.1007/s00392-024-02502-6.


Computed Tomography Angiography Characteristics of Thin-Cap Fibroatheroma in Patients With Diabetes.

Suzuki K, Kinoshita D, Niida T, Yuki H, Fujimoto D, Dey D J Am Heart Assoc. 2024; 13(10):e033639.

PMID: 38742509 PMC: 11179821. DOI: 10.1161/JAHA.123.033639.